BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30274010)

  • 1. Transient EDTA-Dependent Pseudothrombocytopenia Phenomenon in a Patient with Antiphospholipid Syndrome.
    Bai M; Feng J; Liang G
    Clin Lab; 2018 Sep; 64(9):1581-1583. PubMed ID: 30274010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report.
    Ahn HL; Jo YI; Choi YS; Lee JY; Lee HW; Kim SR; Sim J; Lee W; Jin CJ
    Korean J Intern Med; 2002 Mar; 17(1):65-8. PubMed ID: 12014216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant spuriously elevated white blood cell count, a previously underestimated phenomenon in EDTA-dependent pseudothrombocytopenia.
    Xiao Y; Xu Y
    Platelets; 2015; 26(7):627-31. PubMed ID: 25275874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudothrombocytopenia secondary to the effects of EDTA in a dog.
    Wills TB; Wardrop KJ
    J Am Anim Hosp Assoc; 2008; 44(2):95-7. PubMed ID: 18316447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDTA-dependent pseudothrombocytopenia in a child.
    Akbayram S; Dogan M; Akgun C; Caksen H; Oner AF
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):494-6. PubMed ID: 20530050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation factors of ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in cancer patients].
    Kuang MH; Ouyang WT; Lin JH; Liu WL
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(44):3144-6. PubMed ID: 21211347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient pseudothrombocytopenia in a neonate: transmission of a maternal EDTA-dependent anticoagulant.
    Ohno N; Kobayashi M; Hayakawa S; Utsunomiya A; Karakawa S
    Platelets; 2012; 23(5):399-400. PubMed ID: 21988316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDTA-dependent pseudothrombocytopenia in a case of liver cirrhosis.
    Matarazzo M; Conturso V; Di Martino M; Chiurazzi F; Guida G; Morante R
    Panminerva Med; 2000 Jun; 42(2):155-7. PubMed ID: 10965778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudothrombocytopenia in a neonate due to mother?
    Korterink JJ; Boersma B; Schoorl M; Porcelijn L; Bartels PC
    Eur J Pediatr; 2013 Jul; 172(7):987-9. PubMed ID: 23229187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient EDTA-dependent pseudothrombocytopenia in a patient with sepsis.
    Mori M; Kudo H; Yoshitake S; Ito K; Shinguu C; Noguchi T
    Intensive Care Med; 2000 Feb; 26(2):218-20. PubMed ID: 10784313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethylenediaminetetraacetic Acid-induced Pseudothrombocytopenia in Association with Graves' Hyperthyroidism.
    Jing J; Li J; Yu M
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS146-SS148. PubMed ID: 36597320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature.
    Berkman N; Michaeli Y; Or R; Eldor A
    Am J Hematol; 1991 Mar; 36(3):195-201. PubMed ID: 1899964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental analysis and countermeasures for EDTA-dependent Pseudothrombocytopenia].
    Mao WY; Huo M; Ye SD; Gong WB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1345-7. PubMed ID: 25338586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies.
    Houghton DE; Moll S
    Vasc Med; 2017 Dec; 22(6):545-550. PubMed ID: 29103369
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a cardiac surgical patient.
    Dalamangas LC; Slaughter TF
    Anesth Analg; 1998 Jun; 86(6):1210-1. PubMed ID: 9620505
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sudden onset of EDTA-dependent pseudothrombocytopenia in a patient scheduled for open heart surgery].
    Satoh M; Hirose Y; Gamo M; Ohtsuka T; Yonezawa K; Tomioka T; Sakai K
    Masui; 2003 Apr; 52(4):402-5. PubMed ID: 12728492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid syndrome diagnosis: an update].
    Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
    Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pseudothrombocytopenia induced by ethylenediaminetetraacetic acid in burned patients].
    Carrillo-Esper R; Contreras-Domínguez V
    Cir Cir; 2004; 72(4):335-8. PubMed ID: 15469756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.